Your browser doesn't support javascript.
loading
Nanoparticle-mediated dual delivery of resveratrol and DAP5 ameliorates kidney ischemia/reperfusion injury by inhibiting cell apoptosis and inflammation.
Xu, Yong; Zhang, Bo; Xie, Da; Hu, Yu; Li, Hai-Lun; Zhong, Li-Li; Wang, Hong-Wu; Jiang, Wei; Ke, Zun-Ping; Zheng, Dong-Hui.
Afiliación
  • Xu Y; Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
  • Zhang B; Department of Dermatology, Hubei Provincial Hospital of TCM, Hongshan, Wuhan, China.
  • Xie D; Department of Nephrology, The Secend Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Hu Y; Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
  • Li HL; Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
  • Zhong LL; Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
  • Wang HW; Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
  • Jiang W; Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
  • Ke ZP; Department of Cardiology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
  • Zheng DH; Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
Oncotarget ; 8(24): 39547-39558, 2017 Jun 13.
Article en En | MEDLINE | ID: mdl-28465474
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estilbenos / Daño por Reperfusión / Sistemas de Liberación de Medicamentos / Apoptosis / Nanopartículas / Enfermedades Renales Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estilbenos / Daño por Reperfusión / Sistemas de Liberación de Medicamentos / Apoptosis / Nanopartículas / Enfermedades Renales Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos